{"SPADE_UN_00704": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2004/0019181 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2004_0019181_A1", "Patent Type": "Patent Application", "Publication Date": "2004-1-29", "Family Info": "CA2230160A1,DE69637731D1,EP0846128A2,EP0846128B1,US6191254,US7390873,WO1997008199A2,WO1997008199A3", "Patent Title": "Antimicrobial cationic peptides.", "Abstract": "A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."}, {"Patent No": "US 6835536 B2", "Patent Link": "http://www.lens.org/lens/patent/US_6835536_B2", "Patent Type": "Granted Patent", "Publication Date": "2004-12-28", "Family Info": "US4510132,US6503881,US6538106,EP590070,WO9112815,WO0000214,WO0071175", "Patent Title": "Antimicrobial Cationic Peptides And Formulations Thereof", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganismcaused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}, {"Patent No": "US 8927487 B2", "Patent Link": "http://www.lens.org/lens/patent/US_8927487_B2", "Patent Type": "Granted Patent", "Publication Date": "2015-1-6", "Family Info": "US20130296227A1,US13421018,US10865687,US10225087,US60314232,US8466102,EP0930065,WO03015809", "Patent Title": "Antimicrobial cationic peptides and formulations thereof", "Abstract": "Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganismcaused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device."}], "Sequence Information": {"SPADE ID": "SPADE_UN_00704", "Peptide Name": "CP11CN", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "ILKKWPWWPWRRK", "Sequence Length": 13, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=16 µg/ml), S. aureus SAP0017 MRSA (MIC=16 µg/ml), Staphylococcus haemolyticus Clinical isolate (MIC=2 µg/ml), S. haemolyticus Vancomycin-resistant isolate (MIC=1 µg/ml), Staphylococcus epidermidis Clinical isolate (MIC=8 µg/ml), Enterococcus faecalis ATCC 29212 (MIC>64 µg/ml), Listeria monocytogenes NCTC 7973 (MIC=16 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 µg/ml), Corynebacterium xerosis Lab strain (MIC=0.5 µg/ml).(Ref.2)", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C96H138N26O14", "Mass": 1880.29, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": -1.48, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Chemical modification": "C-terminal amidation.", "Literature": [{"Title": "Salt-resistant alpha-helical cationic antimicrobial peptides.", "Pubmed ID": "11294848", "Reference": "Antimicrob. Agents Chemother. 1999,431542-1548.", "Author": "Friedrich, C, M. G. Scott, N. Karunaratne, H. Yan, and R. E. Hancock.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11294848"}], "Frequent Amino Acids": "WKP", "Absent Amino Acids": "ACDEFGHMNOQSTUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 5, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05585", "Similarity": 1.0, "Sequence": "MGAVIKVGAKVIGWGAASGAGLYGLEKILKK"}, {"SPADE_ID": "SPADE_N_10804", "Similarity": 1.0, "Sequence": "KFGKAFVKILKK"}, {"SPADE_ID": "SPADE_N_12471", "Similarity": 1.0, "Sequence": "LKKAKKFGKAFVKILKK"}]}}}